Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Queen Mary University of London
Eastern Cooperative Oncology Group
Radiation Therapy Oncology Group
Academic and Community Cancer Research United
NSABP Foundation Inc
ETOP IBCSG Partners Foundation
Alliance for Clinical Trials in Oncology
National Institute of Oncology, Hungary
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Georgetown University
ETOP IBCSG Partners Foundation
SWOG Cancer Research Network